baber/WOPTO huggingface dataset:
Patent NZ-512917-A (NZ)
Title: Device for horizontally installing strands of wire on a fence
Inventor: BAILEY GEOFF
IPC: E04H17/12
Filed: 2001-07-11
Abstract: A fence wire capture device (10) for mounting on a vertical fence support member comprising a support attachment portion (11) and a wire capture portion (12).  The support attachment portion (11) consists of a pair of opposed jaws (13) defining a channel (14) to mount on a support member such as a star picket fence post.  The wire capture portion (12) consists of a first projection (15) that extends from the support attachment portion (11) and a second projection (16) extending in a plane parallel to, but offset from, the support attachment portion (11) with an upward segment (18) to define an offset slot (19).  In use a fence wire is positioned in the offset slot (19) aligned with the jaws (13) and rotated horizontally to the underside of the first projection (15) to locate the wire.
Patent NZ-521894-A (NZ)
Title: Products containing beta-glucan
Inventor: TSUBAKI KAZUFUMI
IPC: A23L11/00
Filed: 2002-02-14
Abstract: Disclosed is a B-glucan containing fat and oil composition that contains B-glucans which have a weight average molecular weight of less than 500,000 and which are extracted from a gramineous plant, wherein the composition contains a B glucan having at least two kinds of bonds selected from a 1-2-B-D-glucopyranose bond, a 1-3-B-D-glucopyranose bond, a 1-4-B-D-glucopyranose bond, and a 1-6-B-D-glucopyranose bond. Also disclosed is a drug having a prophylactic action for a habitual disease containing the above B-glucan-containing fat and oil composition.
Patent NZ-522723-A (NZ)
Title: Method of enabling use of a communication network by a subscriber including dispensing of a pin code to the cellular telephone user
Inventor: MURRAY ROBERT GEORGE
IPC: G06F/
Filed: 2001-05-09
Abstract: A system for enabling use of a communication network by a subscriber includes: a database including data on a plurality of subscribers requiring use of the communication network; identification means for remotely identifying the subscriber; verification means for verifying subscriber details with reference to the database and a stock of enabling codes from which an enabling code is selectively dispensed to the subscriber, the enabling code being operatively fed into the network to allow communication via the network to a predetermined extent.
Patent NZ-523358-A (NZ)
Title: Quinoline derivatives having VEGF inhibiting activity
Inventor: HENNEQUIN LAURENT FRANCOIS AND
IPC: A61P43/00
Filed: 2001-08-08
Abstract: Quinoline derivative compounds of formula (I) and the pharmaceutically acceptable salts thereof that inhibit the effects of VEGF, a property of value in the treatment of a number of diseases states including cancer and rheumatoid arthritis are disclosed, wherein either any one of G1, G2, G3, G4 and G5 is nitrogen and the other four are -CH-, or G1, G2, G3, G4 and G5 are all -CH-; Z is -O-, -NH-, -S-, -CH2- or a direct bond; Z is linked to any one of G1, G2, G3 and G4; n is an integer from 0 to 5; m is an integer from 0 to 3; Ra represents hydrogen or fluoro; Rb, R1 and R2 are as defined in the specification. Also disclosed is a process for the preparation so such compounds, pharmaceutical compositions containing a compound of formula (I) or a pharmaceutically acceptable salt thereof as active ingredient and the use of a compound of formula I in the manufacture of a medicament for the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blodded animals.
Patent NZ-525333-A (NZ)
Title: Solid compositions suitable for oral administration containing non-hygroscopic salts of L-carnitine and the alkanoyl L-carnitines with taurine chloride and glycine chloride
Inventor: TINTI MARIA ORNELLA
IPC: A61P25/08
Filed: 2001-09-28
Abstract: The application discloses the salt of L-carnitine or alkanoyl L-carnitine with taurine chloride (see formula I below) where R is hydrogen or a straight or branched lower alkanoyl with 2-5 carbon atoms. The compounds disclosed can be used in pharmaceutical preparations in the form of tablets, chewable tablets, capsules, granulates or powders and can be used as a food supplement for human or veterinary use.
Patent NZ-526659-A (NZ)
Title: Packaging bag having mouth opening with its lip turned over, and method of and apparatus for manufacturing the same
Inventor: ROBBIATI FRANCESCO
IPC: B65B9/093
Filed: 2003-06-24
Abstract: A side-sealed packaging bag of plastic film (1) is disclosed, which comprises a first ply (2) and a second film ply (3) joined along an edge (1a) defining the closed end of the bag and along side edges (4,5) of the bag, wherein the mouth of the bag has a first edge (6) on the first ply (2) and a second edge (7) on the second ply (3), which projects beyond the first edge (6) and comprises a folded over film portion, wherein the margin (7a) of the second edge portion (7) is disposed adjacent the first edge (6) of the first ply (2) so as to provide a substantially constant thickness of the bag across the mouth and projecting portion (7), and wherein the length of the folded over film portion is less than 5% of the total length of the bag. A method and an apparatus for manufacturing a plurality of packaging bags are also disclosed.
Patent NZ-527515-A (NZ)
Title: A louvre assembly locking mechanism
Inventor: FERGUSON STUART LYON
IPC: E06B7/084
Filed: 2003-08-12
Abstract: A locking mechanism for the non driven side of a movable louvre assembly. The locking mechanism has at least one control member engageable with the louver blade mounts to form a drive train whereby the louvre mounts can be moved simultaneously. A handle is coupled by a coupling handle to the drive train whereby an angular displacement of the louver mounts can be affected by movement of the handle. A latching means operative in response to movement of the handle to lock the drive train in a locking position.
Patent NZ-529665-A (NZ)
Title: Method for inhibiting calcium salt scale
Inventor: THOMPSON JACOB OWEN
IPC: C09K3/00
Filed: 2002-06-05
Abstract: Disclosed is a method for inhibiting calcium salt scale formation in a chemical pulping process comprising adding an effective scale inhibiting amount of at least one phosphonate compound to the alkaline aqueous mixture in the digester of the chemical pulping process, wherein the phosphonate compound is selected from X2NCH2PO3M2 or amine oxides thereof, or Y-C(R')(PO2M2)-OH.
Patent NZ-530358-A (NZ)
Title: Heterocyclic compound and medicinal use thereof
Inventor: MATSUI HIROSHI
IPC: C07D217/26
Filed: 2002-05-27
Abstract: A heterocyclic compound of formula (I) and a pharmaceutically acceptable salt thereof is disclosed, wherein: R1 represents hydrogen or C1"6 alkyl; R2 represents hydrogen, -CO-C(R4)=C(R4)-R5; wherein R4 is hydrogen or C1-4 alkyl and R5 is C4-8 alkyl, C2-8 alkenyl, etc; Y represents a group of formula (II), wherein X is oxygen or sulfur; R7 has the same meaning as R4; R8 is R10-C(R9)=C(R9)- wherein R9 has the same meaning as R4 and R10 is C3-6 alkyl, etc; R14 has the same meaning as R4; and R15 represents aryl, etc; Y-(CH2)n-O- is bonded to the 6- or 7- positon carbon atom of the tetrahydroisoquinoline skeleton; and n is an integer of 1 to 4. The compound of formula (I) is useful as an antihyperglycemic agent, antihyperlipemic agent, insulin resistance improver, diabetes remedy, remedy for complications of diabetes, glucose intolerance improver, antiarteriosclerotic agent, antiobestic agent, anti"inflammatory agent, preventive/remedy for diseases attributable to PPAR, and preventive/remedy for X syndrome.
Patent NZ-531036-A (NZ)
Title: Controlled-viscosity food flavoring system
Inventor: MORGAN ELLEN
IPC: A23L27/60
Filed: 2002-08-13
Abstract: Disclosed herein is a fiber-free composite food flavouring and/or texturing product having a gelling agent, possibly selected from gelatin, egg white, modified waxy maize starch, whey protein concentrate, modified potato starch, gellan gum, and rennet casein, and a flavoring and/or texturing component, uniformly distributed throughout, possibly selected from nonfat dry milk, butter, enzyme modified cheese, BBQ seasoning blend, cheddar cheese, sugars, milk protein concentrate, vinegar, and partially hydrogenated soybean oil, with the remainder of the composite made up primarily of water. The composite food product is substantially solid and self-sustaining at ambient temperature. Also disclosed is a method for preparing a flavoured and/or textured food item for service by providing a servable portion of an optionally cooked food item, removing a servable portion of the self-sustainable food product from the food product, contacting the servable food portion with the servable food item portion to form a flavoured and/or textured food item combination, normally arranged with the product on top of the food item, and optionally heating the flavoured and/or textured food item combination to prepare the food item for service.
Patent NZ-531539-A (NZ)
Title: Drench system
Inventor: GRANT LINCOLN MATTHEW
Filed: 2004-03-04
Abstract: A backpack for use in a drench system. The backpack 10 includes a back panel 11 with a harness 21 coupled thereto. A front panel 12 is joined by walls 13, 14 to the back panel 11, thereby defining a pouch 15 into which a container C of animal health treatment product can be placed. An opening 18 formed in part of the side wall 14 opposite to an opening in the pouch 15 through which container C can be installed into the pouch. The opening is of a size through which an applicator gun G with attached draw-off hose H extending from the container C can pass when the container is installed in the pouch in an inverted position.
Patent NZ-532181-A (NZ)
Title: Thermal insulation liner
Inventor: LEONG WISMA HONG
IPC: B65D90/04
Filed: 2004-04-06
Abstract: A thermally reflective liner for providing thermal insulation within a container having at least three long panels which are joined along their long sides forming a part tube or tube, an end panel which seals the end of the tube and means for closing the front end part of the tube so that thermal insulation can be provided to the space within the liner and a plurality of first attachments provided along the joined long sides of the liner. At least one piece of webbing material can be held between the plurality of first attachments on the liner and a plurality of second attachments on the container to retain the liner within the container such that an air gap is provided between the sides and top of the liner and the container.
Patent NZ-535737-A (NZ)
Title: Combined goniometer and strength measurement device
Inventor: LE-NGOC LAN
Filed: 2004-10-04
Abstract: Portable systems for measuring angles and forces associated with a joint of a person are disclosed. In one embodiment the system is a handheld device (20) having a housing (22) with a contact surface (26) arranged to contact a body part associated with the joint. A goniometer, force sensor, and control system are all located in the housing. The goniometer measures the angular position of the body part when it is in contact with the contact surface, while the force sensor measures the force applied by the body part. The control system operates the goniometer and force sensor simultaneously to capture angle and force data at the same time.
Patent NZ-537120-A (NZ)
Title: Compositions and methods for transepithelial molecular transport
Inventor: MAKSYMOWYCH ANDREW
IPC: A61K47/48
Filed: 2003-06-02
Abstract: Disclosed are fragments of Clostridium botulinum HC that can be linked with an entity (e.g., an antigen, a particle, or a radionuclide) and used to deliver the entity across a non-keratinized epithelial membrane of an animal. The fragments are useful, for example, for making vaccines, antidotes, and anti-toxins and in situations in which rapid uptake of an agent by an animal is desired.
Patent NZ-543387-A (NZ)
Title: Manipulation of flavonoid biosynthesis in plants (3)
Inventor: SPANGENBERG GERMAN
IPC: C12N15/60
Filed: 2002-10-04
Abstract: A substantially purified or isolated nucleic acid encoding chalcone synthase (CHS) and its polypeptide from a clover (Trifolium) species are described. Vectors and plant cells comprising the nucleic acid are described. The nucleic acid can be introduced into a plant to modify flavonoid biosynthesis, protein binding, metal chelation, anti-oxidation, UV-light absorption, pigment production, plant defense to biotic stress or forage quality, or can be used as a molecular marker.
Patent NZ-544581-A (NZ)
Title: A structural assembly for securing a covering to a frame with a recess in the frame and a seal to hold the covering in place
Inventor: WILLIAMS LLOYD HARVEY
IPC: A01G9/14
Filed: 2004-06-21
Abstract: The invention relates to a structural assembly for the construction of buildings and other types of structures where a covering is secured to a frame. The elongate members (10) of the frame contain a recess that fits a seal (12) for securing the covering to the frame. The seal is spring biased to secure the covering against the frame in at least two places. The system provides for quick assembly and with the use of different types of connectors and joiners, different types of structures of variable design can be formed for temporary or permanent use.
Patent NZ-545713-A (NZ)
Title: Clostridium toxin, and process for the preparation of immunogenic compositions
Inventor: GIBERT MARYSE
IPC: C07K14/33
Filed: 1998-09-17
Abstract: An isolated nucleic acid consisting of SEQ ID NO:3 or a variant thereof that hybridizes with SEQ ID No:3 and retains the signal sequence activity of SEQ ID NO:3. The genetically inactivated toxoid polypeptide form can be used for producing an immunogenic composition for a vaccine. (62) Divided Out of 533498
Patent NZ-548660-A (NZ)
Title: Building structure incorporating cellular-core roof panels spanning from ridge to walls and connected to tension bearing members
Inventor: PRYOR JERRY C
Filed: 2001-11-28
Abstract: The building structure consists of walls erected on a foundation and a roof supported atop the walls. The roof consists of panels 50' each having a cellular core between and bonded to opposed metal sheets. Panels 50' are connected to vertical tension bearing member(s) 162 anchored to the foundation to bear upward forces on the panels 50'.
Patent NZ-551070-A (NZ)
Title: Ammunition with frangible sabot to minimise dangerous high pressure on firing
Inventor: SHARPLIN WILLIAM JAMES
Filed: 2006-11-03
Abstract: A sabot 1 is engaged with a case 3 of the ammunition round so as to form a primer pocket 4 containing a charge 5. The sabot 1 has a central channel 6 which runs from the pocket 4 to a peripheral side of the sabot 7. The round is formed so that when it is fired combustion products proceed through the channel 6 and by acting on the peripheral side part of the sabot 1 cause a forward part to break away and be propelled while leaving the rearward part to be left attached to the case 3.
Patent NZ-552593-A (NZ)
Title: Hand held machine that weeds and mulches
Inventor: DAWSON FREDERICK GEORGE
Filed: 2007-01-15
Abstract: A hand held machine that weeds and mulches is disclosed. An electric or petrol motor 14 with speed control 15 rotates drive shaft 6 which in turn rotates disc 3 having spikes 3. Disc guard 7 is biased by compression spring 8 to cover disc 3 when raised from ground engagement to prevent dirt being hurled from the machine.
Patent NZ-556629-A (NZ)
Title: Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists
Inventor: JANSSENS FRANS EDUARD
IPC: A61K31/4468
Filed: 2006-03-03
Abstract: Disclosed are oxa-diaza-spiro-[5.5]-undecanone derivatives as represented by the general Formula (I), wherein: R2 is Ar2, Ar2-alkyl, di(Ar2)alkyl, Het1 or Het1-alkyl; X is a covalent bond or a bivalent radical selected from O, S, or NR3; Q is O or NR3; each R3 independently from each other, is hydrogen or alkyl; R1 is selected from the group of Ar1, Ar1-alkyl and di(Ar1)-alkyl; n is an integer, equal to 0, 1 or 2; m is an integer, equal to 1 or 2, provided that if m is 2. then n is 1; Z is a covalent bond or a bivalent radical selected from CH-2 or C(=O); A1, A2, A3 and A4 are each independently from each other selected from the group of CH2CH2, C(=O)O and OC(=O), provided that at least one of C(=O)O and OC(=O) is selected and that =O is in an alpha-position relative to the N-atom; and wherein the remaining substituents are as disclosed herein. Also disclosed is the use of a compound as defined above for the manufacture of a medicament for the treatment and / or prophylaxis of tachykinin mediated conditions, and conditions such as schizophrenia, emesis, anxiety and depression, irritable bowel syndrome. circadian rhythm disturbances, pre-eclampsia, nociceprion, pain, in particular visceral and neuropathic pain, pancreatitis, neurogenic inflammation, asthma, chronic obstructive pulmonary disease and micturition disorders such as urinary incontinence.
Patent NZ-561829-A (NZ)
Title: Vehicle suspension system for stable squat magnitude responses
Inventor: WEAGLE DAVID
IPC: B60G21/05
Filed: 2006-04-07
Abstract: A vehicle suspension system for a driven wheel suspension is disclosed. The suspension system projects an instant force center, and achieves a stable squat magnitude curve with a percent squat magnitude variation value from about 0 to about 25 percent when the suspension is compressed from a point of 0 to 100 percent suspension compression.
Patent NZ-571375-A (NZ)
Title: Building sheet and method for detecting weatherproofness of structures
Inventor: HERBERT KYLE LLOYD
IPC: B32B7/00
Filed: 2008-09-18
Abstract: Disclosed is a building sheet having a weight of up to 900g/m2 having a hydrochromatic material applied over at least part of the surface thereof which reversibly changes a detectable optical characteristic viewable through the sheet when exposed to water.
Patent NZ-572100-A (NZ)
Title: A method of depicting an image
Inventor: MERIFIELD MICHAEL JOHN
IPC: G06T3/00
Filed: 2006-04-19
Abstract: A method of depicting an image at a predetermined image position is disclosed. An original image is transformed using an image transformation process. The image transformation process is adapted to transform the original image according to a positional relationship between the predetermined image position and a predetermined viewing position, thereby creating a transformed image for placement on an image surface at said predetermined image position. Transforming the original image includes determining one or more surface characteristics of the image surface; and adapting the image transformation process according to the one or more surface characteristics of the image surface. Adapting the image transformation process can comprises determining how a plane of the image surface differs from a substantially horizontal plane; and adapting the transformed image to compensate for the difference between the plane of the image surface and the horizontal plane. The image surface is a playing surface or field for a sporting event. The transformed image can applied to an image carrier such as a mat with the image carrier being applied to the image surface or the transformed image can be applied directly to the image surface.
Patent NZ-574034-A (NZ)
Title: SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME
Inventor: OKUMURA TADAYOSHI
IPC: A61P3/10
Filed: 2007-06-07
Abstract: Provided is a sense oligonucleotide having activity of suppressing production of NO which promotes decomposition of inducible nitric oxide synthase ( iNOS) mRNA, which has a sequence complementary to iNOS mRNA antisense RNA (antisense transcript of iNOS mRNA). The sense oligonucleotide can be used to treat hepatic disorders.
Patent NZ-583240-A (NZ)
Title: Pharmaceutical composition comprising a sglt2 inhibitor in combination with a dpp-iv inhibitor
Inventor: DUGI KLAUS
IPC: A61K31/00
Filed: 2008-08-15
Abstract: Disclosed is a pharmaceutical composition comprising a SGLT2 inhibitor selected from the group consisting of (1) Dapagliflozin; (2) Remogliflozin or Remogliflozin etabonate; (3) Sergliflozin or Sergliflozin etabonate; (4) 1-Chloro-4-(beta-D-glucopyranos-1-yl)-2-(4-ethyl-benzyl)-benzene; (5) (1S)-1,5-Anhydro-1-[5-(azulen-2-ylmethyl)-2-hydroxyphenyl]-D-glucitol; (6) (1S)-1,5-Anhydro-1-[3-(1-benzothien-2-ylmethyl)-4-fluorophenyl]-D-glucitol; (7) Thiophen derivative of the formula (7-1) wherein R denotes methoxy or trifluoromethoxy; (8) 1-(beta-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2- thienylmethyl]benzene; (9) Spiroketal derivative of the formula (9-1) wherein R denotes methoxy, trifluoromethoxy, ethoxy, ethyl, isopropyl or tert. butyl; or a pharmaceutically acceptable salt, hydrate or solvate thereof; in combination with the DPP IV inhibitor 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine. Also disclosed is the use of the SGL2 and the DPP IV inhibitor in the manufacture of a medicament adapted for administration either in combination or alternately, for preventing, slowing the progression of, delaying or treating a metabolic disorder selected from the group consisting of type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance, impaired fasting blood glucose, hyperglycemia, postprandial hyperglycemia, overweight, obesity and metabolic syndrome.
Patent NZ-586930-A (NZ)
Title: An improved process for preparation of paliperidone
Inventor: CHAVAN AMIT ANANT
IPC: A01N43/90
Filed: 2009-02-05
Abstract: Disclosed is a process for preparing 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one comprising: a) preparing 3-(2-chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one comprising reacting 3-(2-chloroethyl)-2-methyl-9-(phenylmethoxy)-4H-pyrido[1,2-a]pyrimidin-4-one or 3-(2-chloroethyl)-2-methyl-9-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one with hydrogen and a hydrogenation catalyst in an acidic medium to form 3-(2-chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one, removing the acidic media from step (i) and isolating 3-(2-chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one with a solvent selected from the group consisting of ketones, alcohols, water, hydrocarbons and mixtures thereof; b) reacting 3-(2-chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one with 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole·HCI in the presence of a base and an inert solvent selected from the group consisting of alcohols, ketones, esters, ethers, hydrocarbons and mixtures thereof; c) removing the solvent from step (b) and d) isolating paliperidone from a solvent selected from the group consisting of ketones, alcohols, water, hydrocarbons and mixtures thereof.
Patent NZ-587524-A (NZ)
Title: Traction kite safety release device in control bar to activate harness release
Inventor: ROAKE RICHARD JOHN
IPC: B63B35/79
Filed: 2010-08-23
Abstract: Push buttons 8,9 on control bar 2 are activated to cause release mechanism 5 to release a safety harness (not shown) attached to cable 50.
Patent NZ-589374-A (NZ)
Title: Detection of moving objects
Inventor: HINDHEDE AAGE
IPC: G01S13/84
Filed: 2009-03-25
Abstract: Disclosed is a system for detection and position determination of movable objects (8, 10). The objects are each provided with an electronic transceiver unit which by reception of a first signal emits a second signal, the second signal containing a unique information code related to a movable object (8, 10). The electronic transceiver units communicate with at least two fixed transceiver facilities (4, 6) connected with at least one computer. Communication between the fixed transceiver facilities (4, 6) and the electronic transceiver units occurs in an ultra-wideband frequency spectrum in a frequency range from 3.10 GHz to 10.6 GHz and is in the form of transient pulses emitted from the electronic transceiver units. Position determination is performed by calculating time or phase difference between receptions of a signal at at least two transceiver facilities (4, 6).